Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heli Wen
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institution:
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0009-0006-8252-2110
Observed ORCID:
0009-0006-8252-2110
OpenAlex ID:
A5049055940
Global incidence and prevalence of gastritis and duodenitis from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
2024
·
Yinling Xu
, Feichi Chen
, et al.
·
Journal of Gastroenterology and Hepatology
·
17
A real-world pharmacovigilance study of FDA adverse event reporting system events for atogepant
2024
·
Heli Wen
, Yitian Ding
, et al.
·
Expert Opinion on Drug Safety
·
11
Integrating network pharmacology, experimental validation and molecular dynamics simulation to investigate the underlying mechanism of apigenin against diabetic wound
2025
·
Pengpeng Pu
, Fangjian Zheng
, et al.
·
Biochemical and Biophysical Research Communications
·
4
Post-marketing safety of panitumumab: a real-world pharmacovigilance study
2024
·
Heli Wen
, Yuqing Lei
, et al.
·
Expert Opinion on Drug Safety
·
3
Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990–2021
2026
·
Yuanfei Shi
, Tianle Cao
, et al.
·
European journal of medical research
·
2
Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications
2025
·
Feichi Chen
, Di Cai
, et al.
·
Medicine
·
1
Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma
2026
·
Yuanfei Shi
, Heli Wen
, et al.
·
Clinical and Experimental Medicine
Show more works
View as search
Works count:
7
Citation count:
38
H-index:
3
I10-index:
2
Year
Topic
Type